| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.003 | 1 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.00048 | 1 |